Key Points in This Article: Dividend stocks like Altria (MO) offer passive income and compounding returns, ideal for long-term wealth creation.
MO and PM battle for investor favor as smoke-free gains, pricing power and earnings growth reshape their outlooks.
MO uses pricing strength to cushion profits against steep drops in cigarette volumes.
MO hits a 52-week high on earnings growth, oral tobacco gains and rising investor confidence in its long-term strategy.
[00:00:04] Doug McIntyre: Lee.
Altria (MO) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
[00:00:04] Doug McIntyre: Lee, I wanna tell you what I think investors need to take into account now.
Altria's strong Q2 earnings, robust cash flows, and low P/E support my bullish outlook, despite ongoing cigarette declines and regulatory risks. Growth drivers include expanding oral tobacco market share, potential NJOY relaunch, and upcoming On! PLUS launch pending FDA approval. Balance sheet strength, deleveraging progress, and a likely dividend increase add to Altria's investment appeal and upside potential.
MO's on! sales jump in the second quarter, but MST declines and pouch share losses raise questions about sustaining growth.
Stocks with high yields are not supposed to participate in market rallies. Their role is to provide stability and a safe dividend.
Great things require time and patience; so does wealth building. Compound interest, the "eighth wonder of the world", can quietly do the work for you. We discuss our time-tested dividend growth picks with yields of up to 7%.
Altria Group, Inc.'s ( MO ) push into smoke-free products gained further traction in the second quarter of 2025, led by its oral nicotine pouch brand, on!. Shipments of on!